PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011
Abstract
Authors
R.M. Romero Martin A.N. Alvis Nelson D.L.R.M. De los Ríos Magalí C.D. Chávez Diana